Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies

Genetically Modified T-Cell-Based Adoptive Immunotherapy in Hematological Malignancies

A significant proportion of hematological malignancies remain limited in treatment options. Immune system modulation serves as a promising therapeutic approach to eliminate malignant cells. Cytotoxic T lymphocytes (CTLs) play a central role in antitumor immunity; unfortunately, nonspecific approache...

Full description

Bibliographic Details
Main Authors:	Baixin Ye, Creed M. Stary, Qingping Gao, Qiongyu Wang, Zhi Zeng, Zhihong Jian, Lijuan Gu, Xiaoxing Xiong
Format:	Article
Language:	English
Published:	Hindawi Limited 2017-01-01
Series:	Journal of Immunology Research
Online Access:	http://dx.doi.org/10.1155/2017/5210459

Similar Items

Single-Cell Sequencing Technology in Oncology: Applications for Clinical Therapies and Research
by: Baixin Ye, et al.
Published: (2016-01-01)

Advances in Immunotherapy for Glioblastoma Multiforme
by: Boyuan Huang, et al.
Published: (2017-01-01)

Engineering chimeric antigen receptor-T cells for cancer treatment
by: Baixin Ye, et al.
Published: (2018-02-01)

Adoptive Immunotherapy for Hematological Malignancies Using T Cells Gene-Modified to Express Tumor Antigen-Specific Receptors
by: Hiroshi Fujiwara
Published: (2014-12-01)

Meisoindigo, but not its core chemical structure indirubin, inhibits zebrafish interstitial leukocyte chemotactic migration
by: Baixin Ye, et al.
Published: (2017-01-01)

Extracellular vesicle-derived miRNA as a novel regulatory system for bi-directional communication in gut-brain-microbiota axis
by: Liang Zhao, et al.
Published: (2021-05-01)

Adoptive Immunotherapy Strategies with Cytokine-Induced Killer (CIK) Cells in the Treatment of Hematological Malignancies
by: Frederic Carsten Schmeel, et al.
Published: (2014-08-01)

Immunotherapy in Pediatric Hematologic Malignant Neoplasms
by: Kyung Taek Hong
Published: (2020-04-01)

Immune-based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
by: Hermann Einsele, et al.
Published: (2020-08-01)

T Cell Exhaustion and CAR-T Immunotherapy in Hematological Malignancies
by: Lu Tang, et al.
Published: (2021-01-01)

Neoantigens in Hematological Malignancies—Ultimate Targets for Immunotherapy?
by: Malte Roerden, et al.
Published: (2019-12-01)

Immunotherapy in hematologic malignancies: past, present, and future
by: Annie Im, et al.
Published: (2017-04-01)

NK Cell-Based Immunotherapy for Hematological Malignancies
by: Simona Sivori, et al.
Published: (2019-10-01)

Immunotherapy in Hematologic Malignancies: Emerging Therapies and Novel Approaches
by: Ji-Yoon Noh, et al.
Published: (2020-10-01)

PATHOGENESIS, DIAGNOSTICS AND IMMUNOTHERAPY IMMUNOPATHOLOGICAL STATES. CANCERS AND HEMATOLOGICAL MALIGNANCIES
by: Article Editorial
Published: (2015-06-01)

T-Cell Immunotherapies Targeting Histocompatibility and Tumor Antigens in Hematological Malignancies
by: Valérie Janelle, et al.
Published: (2020-02-01)

Molecular Pathogenesis of Anti-NMDAR Encephalitis
by: Hao Ding, et al.
Published: (2015-01-01)

Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs
by: Vanessa Innao, et al.
Published: (2021-12-01)

New Orders to an Old Soldier: Optimizing NK Cells for Adoptive Immunotherapy in Hematology
by: Mehmet Gunduz, et al.
Published: (2021-09-01)

Immunotherapy Frontiers in Hematology
by: Simon Hallam, MA, PhD, MRCP, FRCPath
Published: (2017-12-01)

Gene Modified CAR-T Cellular Therapy for Hematologic Malignancies
by: Wen-Ying Lin, et al.
Published: (2020-11-01)

Meisoindigo Protects Against Focal Cerebral Ischemia-Reperfusion Injury by Inhibiting NLRP3 Inflammasome Activation and Regulating Microglia/Macrophage Polarization via TLR4/NF-κB Signaling Pathway
by: Yingze Ye, et al.
Published: (2019-12-01)

Targeting Oxidative Stress and Inflammation to Prevent Ischemia-Reperfusion Injury
by: Liquan Wu, et al.
Published: (2020-03-01)

The “Magic Bullet” Is Here? Cell-Based Immunotherapies for Hematological Malignancies in the Twilight of the Chemotherapy Era
by: Nina Miazek-Zapala, et al.
Published: (2021-06-01)

154 Marrow-infiltrating lymphocytes (MILs): A novel adoptive immunotherapy for hematological and solid tumors
by: David Page, et al.
Published: (2020-11-01)

From CAR-T Cells to CAR-NK Cells: A Developing Immunotherapy Method for Hematological Malignancies
by: Hui Lu, et al.
Published: (2021-08-01)

Bidirectional gut-brain-microbiota axis as a potential link between inflammatory bowel disease and ischemic stroke
by: Liang Zhao, et al.
Published: (2018-12-01)

A New Hope in Immunotherapy for Malignant Gliomas: Adoptive T Cell Transfer Therapy
by: Dong-Sup Chung, et al.
Published: (2014-01-01)

Lymphoid hematological malignancies
by: D. A. Domninskiy
Published: (2014-07-01)

Myeloid hematological malignancies
by: D. A. Domninsky
Published: (2014-07-01)

Lymphoid hematological malignancies
by: D. A. Domninskiy
Published: (2014-07-01)

Neoantigens in Hematologic Malignancies
by: Melinda A. Biernacki, et al.
Published: (2020-02-01)

Myeloid hematological malignancies
by: D. A. Domninsky
Published: (2014-07-01)

Deubiquitinases in hematological malignancies
by: Hu Lei, et al.
Published: (2021-08-01)

Advances in Hematologic Malignancies
Published: (2019)

Vγ9Vδ2 T cells as a promising innovative tool for immunotherapy of hematologic malignancies
by: Serena Meraviglia, et al.
Published: (2011-12-01)

Microarray Gene Expression Analysis to Evaluate Cell Type Specific Expression of Targets Relevant for Immunotherapy of Hematological Malignancies.
by: M J Pont, et al.
Published: (2016-01-01)

Genetic Variants as Targets for Immunotherapy of Hematological Tumors
Published: (2020)

HEMATOLOGICAL MALIGNANCIES. LYMPHOCYTIC LEUKAEMIA
by: Peter F. Litvitsky, et al.
Published: (2016-11-01)

Aspergillosis in patients with hematological malignancies
by: N. B. Bulieva
Published: (2014-07-01)

Cannot write session to /tmp/vufind_sessions/sess_dqvnqu58hm2iegu984vivcorv3